Become a donor or member and support our work to advance access to medicines. For everyone. Everywhere
Abysmal decisions: Why the EC’s medicinal units shouldn’t be moved to DG Industry
Setting precedents: EMA must get clinical trial data policy right to truly act in public interest
HAI Europe calls on EMA's Management Board to stand for data transparency
BMJ statins debate about scientific independence, not rigour
World Health Assembly 67: HAI intervention on the WHO's framework of engagement with non-state actors
Enhancing accountability in the medicines market: The Medicines Transparency Alliance
Regulation critical to clinical trials data transparency in Europe
True clinical trials transparency? Not quite, EFPIA.
Statement on conflicts of interest delivered at WHA on behalf of HAI, Berne Declaration, KEI, TWN, PHM, IBFAN
Conflicts of Interest and the Future of Financing for WHO.
Foundations: Conlicts of interests and Democracy issues
European drug regulator challenged over revolving door case involving former Director
Corporate funding linked to EU patient & consumer groups policy